Table 1.
Comparison of baseline demographic profiles and history of comorbidities between the control and PLA cohorts.
| Variable | Control cohort N = 102120 (%) | PLA cohort N = 25530 (%) | p value |
|---|---|---|---|
| Age, year (SD) | 59.3 (14.6) | 59.4 (14.6) | 0.29 |
| Sex | >0.99 | ||
| Female | 37752 (37.0) | 9438 (37.0) | |
| Male | 64368 (63.0) | 16092 (63.0) | |
| Comorbidities | |||
| Osteoporosis | 2164 (2.1) | 541 (2.1) | >0.99 |
| Liver cirrhosis | 706 (0.7) | 743 (2.9) | <0.01 |
| CAD | 6138 (6.0) | 2554 (10.0) | <0.01 |
| DM | 14748 (14.4) | 10264 (40.2) | <0.01 |
| Epilepsy | 304 (0.3) | 131 (0.5) | <0.01 |
| Hypertension | 12459 (12.2) | 7421 (29.1) | <0.01 |
| Stroke | 5477 (5.4) | 2084 (8.2) | <0.01 |
| ESRD | 532 (0.5) | 594 (2.3) | <0.01 |
| COPD | 3056 (3.0) | 1293 (5.1) | <0.01 |
PLA: pyogenic liver abscess; CAD: coronary artery disease; DM: diabetes mellitus; ESRD: end-stage renal disease; COPD: chronic obstructive pulmonary disease.